Detalhe da pesquisa
1.
How do we use the National Healthcare Safety Network for Hemovigilance in Massachusetts?
Transfusion
; 64(2): 200-209, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38158876
2.
Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States.
Transfusion
; 59(2): 524-533, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30427540
3.
Enhancing hemotherapy safety through pertinent diagnostic testing and electronic "provisional diagnosis" reporting: expanding roles for blood bank technologists in biovigilance and patient safety.
Transfusion
; 58(7): 1708-1717, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29984417
4.
Hemovigilance in Massachusetts and the adoption of statewide hospital blood bank reporting using the National Healthcare Safety Network.
Transfusion
; 57(2): 478-483, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27774608
5.
Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion-associated circulatory overload have proinflammatory aspects?
Transfusion
; 52(11): 2310-20, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23216230
6.
A Comparison of Transfusion-Related Adverse Reactions Among Apheresis Platelets, Whole Blood-Derived Platelets, and Platelets Subjected to Pathogen Reduction Technology as Reported to the National Healthcare Safety Network Hemovigilance Module.
Transfus Med Rev
; 35(2): 78-84, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33934903